Latent myasthenia gravis revealed by protracted postoperative effect of non-depolarizing neuromuscular blockade.
Shoji
S
Ito
Yoshihito
Y
Fujita
Hiroshi
H
Sasano
Kazuya
K
Sobue
D000368:Aged; D000768:Anesthesia, General / Q000009:adverse effects*; D000906:Antibodies / Q000032:analysis; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000139:chemically induced* / Q000628:therapy*; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D011183:Postoperative Complications / Q000139:chemically induced* / Q000628:therapy; D011950:Receptors, Cholinergic / Q000276:immunology; D012121:Respiration, Artificial; D013945:Thymoma / Q000150:complications / Q000175:diagnosis; D013953:Thymus Neoplasms / Q000150:complications / Q000175:diagnosis; D014599:Uterus / Q000601:surgery; D014673:Vecuronium Bromide / Q000009:adverse effects*
D000906:Antibodies; D003473:Neuromuscular Nondepolarizing Agents; D011950:Receptors, Cholinergic; D014673:Vecuronium Bromide